These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 4260802)

  • 21. Effect of some drugs on central monoamine nerve terminals lacking nerve impulse flow.
    Andén NE; Fuxe K; Hökfelt T
    Eur J Pharmacol; 1967 May; 1(3):226-32. PubMed ID: 5234370
    [No Abstract]   [Full Text] [Related]  

  • 22. R 28935 and prazosin: effects on central and peripheral alpha-adrenoreceptor activity and on blood pressure.
    Andén NE; Gomes C; Persson B; Trolin G
    Naunyn Schmiedebergs Arch Pharmacol; 1978 May; 302(3):299-306. PubMed ID: 208008
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of DOPA on the spinal cord. 2. A pharmacological analysis.
    Andén NE; Jukes MG; Lundberg A
    Acta Physiol Scand; 1966; 67(3):387-97. PubMed ID: 5967602
    [No Abstract]   [Full Text] [Related]  

  • 24. Behavioural and biochemical effects of L-dopa after inhibition of dopamine- -hydroxylase in reserpine pretreated rats.
    Ahlenius S; Engel J
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 270(4):349-60. PubMed ID: 4255378
    [No Abstract]   [Full Text] [Related]  

  • 25. Locomotor stimulation by L-dopa: relative importance of noradrenaline receptor activation.
    Andén NE; Strömbom U; Svensson TH
    Psychopharmacology (Berl); 1977 Nov; 54(3):243-8. PubMed ID: 413140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On spinal noradrenaline receptor supersensitivity: correlation between nerve terminal densities and flexor reflexes various times after intracisternal 6-hydroxydopamine.
    Nygren LG; Olson L
    Brain Res; 1976 Nov; 116(3):455-70. PubMed ID: 974787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Release of dopamine from central noradrenaline nerves after treatment with reserpine plus amphetamine.
    Andén NE; Svensson TH
    J Neural Transm; 1973; 34(1):23-30. PubMed ID: 4714591
    [No Abstract]   [Full Text] [Related]  

  • 28. Degeneration of central and peripheral noradrenaline neurons produced by 6-hydroxy-DOPA.
    Sachs C; Jonsson G
    J Neurochem; 1972 Jun; 19(6):1561-75. PubMed ID: 5035304
    [No Abstract]   [Full Text] [Related]  

  • 29. Noradrenaline uptake mechanisms in human atrium.
    Sachs C; Jonsson G
    Acta Pharmacol Toxicol (Copenh); 1972; 31(5):456-70. PubMed ID: 4678827
    [No Abstract]   [Full Text] [Related]  

  • 30. Biochemical and histochemical studies on the effects of imipramine-like drugs and (+)-amphetamine on central and peripheral catecholamine neurons.
    Carlsson A; Fuxe K; Hamberger B; Lindqvist M
    Acta Physiol Scand; 1966; 67(3):481-97. PubMed ID: 5967609
    [No Abstract]   [Full Text] [Related]  

  • 31. Spinal noradrenaline mechanisms and blood pressure: effect of local treatment with 6-hydroxydopamine in the rat.
    Henning M; Pernevi P; Trolin G
    Med Biol; 1974 Oct; 52(5):336-42. PubMed ID: 4427465
    [No Abstract]   [Full Text] [Related]  

  • 32. Apomorphine induced biting and fighting behaviour in reserpinized rats and an approach to the mechanism of action.
    Patni SK; Dandiya PC
    Life Sci; 1974 Feb; 14(4):737-45. PubMed ID: 4856759
    [No Abstract]   [Full Text] [Related]  

  • 33. Mechanisms of hyperglycemic response to chlorpromazine administered into lateral ventricle in rats. I. Possible role of dopaminergic nervous system.
    Fujimori K; Iwamoto T
    Neuropharmacology; 1974 Apr; 13(4):245-54. PubMed ID: 4853135
    [No Abstract]   [Full Text] [Related]  

  • 34. On the beta-hydroxylation of (+-)-alpha-methyldopamine in vivo.
    Carlsson A; Meisch JJ; Waldeck B
    Eur J Pharmacol; 1968 Dec; 5(1):85-92. PubMed ID: 5718522
    [No Abstract]   [Full Text] [Related]  

  • 35. Different alpha-adrenoreceptors in the central nervous system mediating biochemical and functional effects of clonidine and receptor blocking agents.
    Andén NE; Grabowska M; Strömbom U
    Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(1):43-52. PubMed ID: 6918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional role of the nigro-neostriatal dopamine neurons.
    Andén NE; Dahlström A; Fuxe K; Larsson K
    Acta Pharmacol Toxicol (Copenh); 1966; 24(2):263-74. PubMed ID: 5297995
    [No Abstract]   [Full Text] [Related]  

  • 37. The occurrence of biogenic monoamines in the mammalian endocrine pancreas.
    Cegrell L
    Acta Physiol Scand Suppl; 1968; 314():1-60. PubMed ID: 4973243
    [No Abstract]   [Full Text] [Related]  

  • 38. Dissociate destruction of noradrenaline and dopamine descending projections in the thoracic spinal cord of the rat.
    Mouchet P; Guerin B; Feuerstein C
    Life Sci; 1982 Jan; 30(4):373-81. PubMed ID: 7070213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monoamines in the bird median eminence. Failure of cocaine to block the accumulation of exogenous amines.
    Björklund A; Falck B; Ljunggren L
    Z Zellforsch Mikrosk Anat; 1968; 89(2):193-200. PubMed ID: 5700266
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of dopamine-like drugs on rat striatal adenyl cyclase have implications for CNS dopamine receptor topography.
    Miller R; Horn A; Iversen L; Pinder R
    Nature; 1974 Jul; 250(463):238-41. PubMed ID: 4368645
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.